Search results
Results from the WOW.Com Content Network
Carcinoembryonic antigen (CEA) describes a set of highly-related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Consequently, CEA is usually present at very low levels in the blood of healthy adults (about 2–4 ng/mL). [2]
n/a Ensembl ENSG00000105388 n/a UniProt P06731 n/a RefSeq (mRNA) NM_001291484 NM_001308398 NM_004363 n/a RefSeq (protein) NP_001278413 NP_001295327 NP_004354 n/a Location (UCSC) Chr 19: 41.71 – 41.73 Mb n/a PubMed search n/a Wikidata View/Edit Human Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) also known as CD66e (C luster of D ifferentiation 66e), is a member of the ...
Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1) also known as CD66a (Cluster of Differentiation 66a), is a human glycoprotein, and a member of the carcinoembryonic antigen (CEA) gene family.
Pregnancy-specific beta-1-glycoprotein is a major product of the syncytiotrophoblast in the placenta, reaching concentrations of 100 to 290 mg/L at term in the serum of pregnant women. [3] [12] PSGs are synthesized through a gene's coding for a specific protein.
n/a Ensembl ENSG00000242221 n/a UniProt P11465 n/a RefSeq (mRNA) NM_031246 n/a RefSeq (protein) NP_112536 n/a Location (UCSC) Chr 19: 43.06 – 43.08 Mb n/a PubMed search n/a Wikidata View/Edit Human Pregnancy-specific beta-1-glycoprotein 2 is a protein that in humans is encoded by the PSG2 gene. References ^ Teglund, Stephan; Olsen, Anne; Khan, Wasif Noor; Frångsmyr, Lars; Hammarström, Sten ...
The objective of this study was to compare different tumor markers and their diagnostic value. The tumor markers tested in this experiment were CA 19-9, CA 242 and CEA tumor markers. The data revealed that although each marker have its own level of specificity and correspond to a cancer, all three makers together increase diagnostic value. [7]
With the start of a new year on Jan. 1, 2025, comes the emergence of a new generation. 2025 marks the end of Generation Alpha and the start of Generation Beta, a cohort that will include all ...
The reason is that the test may be falsely normal (false negative) in many cases or abnormally elevated in people who have no cancer (false positive) in others. The main use of CA19-9 is therefore to see whether a pancreatic tumor is secreting it; if that is the case, then the levels should fall when the tumor is treated, and they may rise ...